In human liver cancer cells, OKN-007 was noted to have an anti-tumor effect by suppression of both the transforming growth factor β1 (TGFβ1)/SMAD and Hedgehog/GLII signaling pathway by inhibiting sulfatase 2 (SULF2) enzyme activity [10]. The gene discussed is SULF2; the disease is liver cancer.